探索RPLP0,RPLP1和RPLP2表达在肺腺癌中的功能和预后价值
Chunyan Xu1, Zhimin Lu2, Guoxin Hou3
1Department of Pulmonary and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai, China.
Journal of molecular histology
|August 29, 2024
概括
核糖体蛋白RPLP0,RPLP1和RPLP2在肺腺癌 (LUAD) 中过度表达,与患者预后不佳相关,并影响免疫透. 这些蛋白质可能代表LUAD治疗的新疗法标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 肺腺癌 (LUAD) 是非小细胞肺癌 (NSCLC) 的一个主要亚型,结果不佳.
- 核糖体蛋白质RPLP0,RPLP1和RPLP2已知在各种癌症中起作用,但它们在LUAD中的特定功能尚不清楚.
研究的目的:
- 为了研究核糖体蛋白RPLP0,RPLP1和RPLP2在LUAD中的作用和预后意义.
- 探索这些蛋白质的表达与临床结果,免疫细胞透以及在LUAD中的潜在治疗策略之间的相关性.
主要方法:
- 对LUAD患者数据进行了全面的生物信息分析.
- 对基因表达的分析,拷贝数变异和促进物甲基化.
- 与整体存活率,第一次进展和进展后的存活率的相关性分析.
- 研究免疫细胞透和药物基因相互作用.
主要成果:
- 在LUAD组织中,RPLP0,RPLP1和RPLP2显著过度表达.
- 过度表达与拷贝数变化和促进物甲基化降低有关.
- 高RPLP0,RPLP1或RPLP2表达与较差的整体存活率,首次进展和进展后的存活率相关.
- 这些蛋白质的表达水平会影响LUAD中的免疫细胞透.
- 确定了对RPLP1和RPLP2的潜在抑制药物.
结论:
- 在LUAD中,RPLP0,RPLP1和RPLP2具有致癌作用.
- 这些核糖体蛋白质作为LUAD患者的宝贵预后生物标志物.
- 针对RPLP1和RPLP2可能为LUAD提供治疗途径.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
